New diabetes drugs also shown to slow kidney decline Dialysis company FMC sees impact on its grow outlook Fresenius Medical in push into earlier stages of kidney disease Separate Reuters factbox gives ...
Treatment with dapagliflozin led to a statistically significant improvement in HbA1c compared with placebo. The Food and Drug Administration (FDA) has expanded the approval of Farxiga ® (dapagliflozin ...
AstraZeneca’s latest DTC spot “We Are Targets” for its chronic kidney disease (CKD) med Farxiga is aimed squarely at the nine in 10 adults who have CKD but are unaware of it. The new spot is a ...
Dear Dr. Roach: My question is: What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet and 1 inch tall. I was treated for heart ...
The world’s largest dialysis company is seeking out kidney disease patients long before they need the most acute form of care as it plans for growth of new drugs that attack the condition’s causes ...
FRANKFURT (Reuters) -The world’s largest dialysis company is seeking out kidney disease patients long before they need the most acute form of care as it plans for growth of new drugs that attack the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback